EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -0.0547
March 31, 2026 -0.0517
December 31, 2025 -0.0775
September 30, 2025 -0.1344
June 30, 2025 -0.075
March 31, 2025 -0.0858
December 31, 2024 -0.083
September 30, 2024 -0.2302
June 30, 2024 -0.282
March 31, 2024 -0.3908
December 31, 2023 -0.2968
September 30, 2023 -0.4814
June 30, 2023 -0.2758
March 31, 2023 -0.7913
December 31, 2022 -14.11
September 30, 2022 -14.95
June 30, 2022 -1.102
March 31, 2022 -1.240
December 31, 2021 -1.199
September 30, 2021 -1.299
June 30, 2021 -0.9477
March 31, 2021 -0.8172
December 31, 2020 -8.751
September 30, 2020 -0.6231
June 30, 2020 -0.5856
Date Value
March 31, 2020 -0.5714
December 31, 2019 -0.5224
September 30, 2019 -0.5898
June 30, 2019 -0.8492
March 31, 2019 -0.7382
December 31, 2018 -0.5608
September 30, 2018 -0.5283
June 30, 2018 -0.60
March 31, 2018 -0.712
December 31, 2017 -0.75
September 30, 2017 -0.90
June 30, 2017 -0.60
March 31, 2017 -0.75
December 31, 2016 -0.75
September 30, 2016 -1.05
June 30, 2016 -1.05
March 31, 2016 -1.35
December 31, 2015 -1.50
September 30, 2015 -1.50
June 30, 2015 -1.65
March 31, 2015 -1.50
December 31, 2014 -1.65
September 30, 2014 -2.40
June 30, 2014 -2.25
March 31, 2014 -1.65

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 4.267
Neogen Corp. -0.0519
QuidelOrtho Corp. -1.360
VolitionRX Ltd. -0.8505
Lucid Diagnostics, Inc. -0.0804